0001562180-16-001810.txt : 20160225 0001562180-16-001810.hdr.sgml : 20160225 20160225170005 ACCESSION NUMBER: 0001562180-16-001810 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160225 FILED AS OF DATE: 20160225 DATE AS OF CHANGE: 20160225 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001369786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 BUSINESS PHONE: 847-908-1604 MAIL ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 FORMER COMPANY: FORMER CONFORMED NAME: Sagent Holding Co. DATE OF NAME CHANGE: 20090529 FORMER COMPANY: FORMER CONFORMED NAME: NHS PHARMACEUTICALS DATE OF NAME CHANGE: 20060720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krizman Anthony CENTRAL INDEX KEY: 0001517892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35144 FILM NUMBER: 161456696 MAIL ADDRESS: STREET 1: C/O SAGENT PHARMACEUTICALS, INC. STREET 2: 1901 N. ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-02-25 false 0001369786 Sagent Pharmaceuticals, Inc. SGNT 0001517892 Krizman Anthony C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 true false false false Common Stock 2016-02-25 4 M false 460.00 0.00 A 6867.00 D Common Stock 2016-02-25 4 M false 230.00 0.00 A 7097.00 D Restricted Stock Units 2016-02-25 4 M false 460.00 0.00 D Common Stock 460.00 1381.00 D Restricted Stock Units 2016-02-25 4 M false 230.00 0.00 D Common Stock 230.00 691.00 D Vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of SGNT common stock. The restricted stock units vest in four equal annual installments beginning on February 25, 2016. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date. /s/ Anthony Krizman 2016-02-26